Report Overview: Future of the Mexican Defense Market Forecasts to 2018

Description

Product Synopsis

This report is the result of SDI's extensive market and company research covering the Mexican defense industry, and provides detailed analysis of both historic and forecast defense industry values including key growth stimulators, analysis of the leading companies in the industry, and key news.

To Read the Complete Report with TOC Visit: http://www.marketresearchreports.biz/analysis-details/future-of-the-mexican-defense-industry-market-attractiveness-competitive-landscape-and-forecasts-to-2018

Introduction and Landscape

Why was the report written?

The Future of the Mexican Defense Industry - Market Attractiveness, Competitive Landscape and Forecasts to 2018 offers the reader an insight into the market opportunities and entry strategies adopted by foreign original equipment manufacturers (OEMs) to gain a market share in the Mexican defense industry.

What is the current market landscape and what is changing?

Mexican defense expenditure, which stands at US$6.5 billion in 2013, increased at a CAGR of 10.1% during the review period. On a cumulative basis, the country is expected to spend an estimated US$42 billion on its armed forces during the forecast period. However, the country's overall defense spending is anticipated to register a CAGR of 11.2% during the forecast period and value US$10.28 billion in 2018. Military spending is expected to be driven by factors such as efforts in combating drug trafficking and the acquisition of advanced defense systems.

To Buy The Copy of This Report Visit : http://www.marketresearchreports.biz/analysis/172372       

Contact

M/s Sheela

90 Sate Street, Suite 700

Albany, NY 12207

USA – Canada Toll Free: 866-997-4948

Email: sales@marketresearchreports.biz

Website: http://www.marketresearchreports.biz/

Blog: http://industry-research-reports.blogspot.com/

Report Overview: Global and China Monoclonal Antibody Market Analysis 2013-2017

Antibody drugs are usually generated from monoclonal antibody through genetic engineering, with the advantages of strong targeting, few side effects, etc. With rather promising application prospect in clinic treatment, antibody drugs are mainly applied in curing diseases like tumour, immune system and so on. In terms of the global market, antibody drugs account for over 40% of the entire biotech drug market and the market share still keeps increasing. Antibody drugs have become one of the most important parts of biotech drugs and monoclonal antibody drugs are even star products of antibody drugs. Among the top 10 best selling drugs in 2012, six of them were monoclonal antibody drugs with each annual sales value exceeding USD 5 billion.

To Read the Complete Report with TOC Visit: http://www.marketresearchreports.biz/analysis-details/research-report-on-global-and-china-monoclonal-antibody-industry-2013-2017

In recent years, the market scale of monoclonal antibody drugs increased rapidly. In 2012, the global sales value of monoclonal antibody preparation exceeded USD 50 billion. Among that, Roche (plus Genentech) was the leading monoclonal antibody enterprises, which possessed seven products sold in the market including Avastin, Herceptin, Rituximab, etc. In 2012, its sales value of monoclonal antibody products reached USD 20 billion. Mono antibody drugs will become the main force promoting the development of biological drugs in the next few years.

In recent years, China bio pharmaceuticals industry develops rapidly, but antibody drugs lag far behind the average international level with sales value being less than 3% of biological drug share. At present, China antibody drug market is still in the initial stage. However, with Shanghai CITIC National Health Pharmaceutical Co., Ltd. and Biotech Pharmaceutical Co., Ltd. releasing humanization products, product types of domestic antibody drugs will enter the upgrading stage. Although domestic full humanization products have not been released, humanization products and full humanization products will become the domestic trend of monoclonal antibody products in the future.

To Buy The Copy of This Report Visit : http://www.marketresearchreports.biz/analysis/172373      

Contact

M/s Sheela

90 Sate Street, Suite 700

Albany, NY 12207

USA – Canada Toll Free: 866-997-4948

Email: sales@marketresearchreports.biz

Website: http://www.marketresearchreports.biz/

Blog: http://industry-research-reports.blogspot.com/

Market study Report: The Renal Denervation Market Growth

Hypertension: Prevalence and Significance

Hypertension is one of the most preventable causes of premature morbidity and mortality globally. It is a major risk factor for stroke, myocardial infarction, heart failure, chronic kidney disease, peripheral vascular disease, cognitive decline, damage to retinal blood vessels and visual impairment, and premature death. Therefore, reducing hypertension can lower the incidence of these conditions, helping to improve the health of the population and reducing the high burdens that they place on global healthcare systems.

To Read the Complete Report with TOC Visit: http://www.marketresearchreports.biz/analysis-details/challenges-and-opportunities-in-the-renal-denervation-market

Renal denervation therapy involves a surgical procedure and is therefore a last resort in the treatment of hypertension. It is only considered when cheaper, simpler and potentially safer alternatives such as lifestyle modifications and the use of pharmaceuticals have failed. These patients are termed as having treatment-resistant hypertension.

Current Trends and Future Opportunities

With renal denervation technology only having been in development since the late 1990s and commercially-available since 2010, the market is in its infancy. The products remain unapproved in the US and Japan, and reimbursement is not yet widely available in other regions. Despite being an emerging market, renal denervation has sparked considerable interest due to the good safety and efficacy results it has achieved so far in helping to reduce treatment-resistant hypertension. The expectation is that renal denervation could become a multi-billion dollar market in the future. However, the success of any new medical technology is dependent on regulatory approval and reimbursement; acceptance and awareness from the medical community; and evidence of safety, efficacy and cost-effectiveness. All of these elements must be in place for the market to realise its potential.

Understand the current trends and future opportunities to invest in, in this essential report, and learn about the products and technologies leading this dynamic market. Challenges and Opportunities in the Renal Denervation Market is the complete guide with all you need to know!

To Buy The Copy of This Report Visit : http://www.marketresearchreports.biz/analysis/172371     

Contact

M/s Sheela

90 Sate Street, Suite 700

Albany, NY 12207

USA – Canada Toll Free: 866-997-4948

Email: sales@marketresearchreports.biz

Website: http://www.marketresearchreports.biz/

Blog: http://industry-research-reports.blogspot.com/

Study Report: The World Medical Markets Trends Fact Book 2013

Description

The indispensable source of thousands of facts, figures and statistics for 67 medical markets worldwide!

The World Medical Markets Fact Book 2013 is the ideal companion in today’s challenging medical market environment. The need to understand world medical marketplaces, and be able to answer quickly those questions that arise daily, is essential. That is why this current and comprehensive source of key market statistics is an invaluable aid for every medical device industry executive.

To Read the Complete Report with TOC Visit: http://www.marketresearchreports.biz/analysis-details/the-world-medical-markets-fact-book-2013

Proven and reliable

Published by Espicom - experts in the healthcare field for over 30 years, the Fact Book brings together a range of often difficult to source information in one single, convenient and comprehensive publication.

Key market questions answered by The World Medical Markets Fact Book 2013

• Which country spends most on medical devices as a % of GDP?
• How are the economic downturn and currency fluctuations affecting expenditure in key Asian markets?
• Which medical device sectors are growing the fastest and where?
• How does the Brazilian medical market compare with China and India in terms of total health expenditure?
• What demographic development is affecting the market in Central and Eastern Europe?
• What have been the key trends affecting medical technology companies in leading Latin American markets?

Over 25,000 data points at your fingertips! Which other business reference provides…

• Key economic, demographic and health statistics on 67 markets around the world
• Five years of historical data for markets, GDP & healthcare spending, demographics and healthcare statistics
• World/regional overviews plus statistics on individual countries
• Over 500 tables and charts delivered in a single PDF report
• PLUS an additional interactive data tool included in the price, where you can segment, compare and export the data in any way that you wish, to suit your information needs 

To Buy The Copy of This Report Visit : http://www.marketresearchreports.biz/analysis/172331    

Contact

M/s Sheela

90 Sate Street, Suite 700

Albany, NY 12207

USA – Canada Toll Free: 866-997-4948

Email: sales@marketresearchreports.biz

Website: http://www.marketresearchreports.biz/

Blog: http://industry-research-reports.blogspot.com/